Form D · Biotechnology
Camras Vision, Inc.
Research Triangle Park, NC · CIK 0001638025
Offering snapshot reported Nov 28, 2017 · SEC filing
- Reported sold
- $3M Offering amount: $7M
- Investors reported
- 49 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 21, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 28, 2017 | Initial | $3,003,391 | No comparison | 49 | SEC filing |
| Apr 14, 2016 | Amendment | $1,269,700 | $1,094,700vs May 12, 2015 | 34 | SEC filing |
| May 12, 2015 | Initial | $175,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-299545
Source: Form D, filed Nov 28, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Roberto Alfaro | Director, Executive, Promoter |
| Lucinda Camras | Director, Executive, Promoter |
| Ray Krauss | Director, Executive |
| Robert Rothman | Director |
| Timothy Willis | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2 Davis Drive
Research Triangle Park, NC, 27709
Research Triangle Park, NC, 27709